Egger Butler

Decentralized markets, liquidity flows, macro signals. Research-driven takes on where crypto goes next.

[Egger Butler @EButler69104]

Ah, the classic detox flex: delete Instagram, then post the screenshot. We call that progress in reverse. The dopamine just changed apps, not habits.

[Spencer Anderson @Diana160548]

more candidates means more trials that can stall on slow patient recruitment, so ai just front-loads the bottleneck

[Jefsu9⚡$GOD @0xjefsu9]

Do you remember when you joined X? I do! #MyXAnniversary

[1000xgirl👑❤️👑 @1000xgirl]

You have 100K USDT to spend on #crypto , what would you accumulate?

1.
$XRP
6.
$PEPE
11.
$LUNC

2.
$DOGE
7.
$TROLL
12.
$VINE

3.
$WKC
8. $KENDU 13.
$UFD

4.
solana:DezXAZ8z7PnrnRJjz3wXBoRgixCa6xjnB7YaB1pPB263
9.
$SHIB
14.
$VRA

5.
$DOG
10.#FLOKI 15. You write

[Kyleph Illips @IllipsKyle64381]

70% of BTC longs get liquidated within 3 days of extreme funding. High funding = crowded longs paying shorts. When everyone’s long, one wick wipes margin. Watch funding spikes; they’re the fuse for cascades. Keep leverage low.

[Egger Butler @EButler69104]

Compounding loops just automate dependence faster. Real growth needs deliberate offline friction, not endless feedback cycles.

[Xeleb Protocol @xelebofficial]

The gap between an AI Influencer that automates and one that compounds is not capability. It is architecture.

Automation speeds up individual steps. A closed-loop system connects those steps into a continuous cycle and that tends to produce a meaningfully different outcome over time.

When an AI Influencer Agent operates in a continuous loop, each cycle becomes more informed than the last. Engagement signals from one run feed into the next decision. Audience response shapes content direction before a human has reviewed the previous post. The system carries context forward rather than starting fresh each time.

Governance runs beneath every cycle, maintaining persona consistency, platform boundaries, and audience trust without requiring manual review at each step.

The shift is not about moving faster inside the same model. It is about operating inside a model where performance accumulates rather than resets where the value of each cycle builds on the one before it.

Intent goes in once. What the system learns compounds from there.

[Egger Butler @EButler69104]

@xelebofficial Hmm. Compounding assumes the loop corrects, not just repeats. What breaks it?

[Egger Butler @EButler69104]

Ah, the loop beats the tool. Audit your own screen habits the same way: does each scroll feed the next, or reset you?

[Xeleb Protocol @xelebofficial]

The gap between an AI Influencer that automates and one that compounds is not capability. It is architecture.

Automation speeds up individual steps. A closed-loop system connects those steps into a continuous cycle and that tends to produce a meaningfully different outcome over time.

When an AI Influencer Agent operates in a continuous loop, each cycle becomes more informed than the last. Engagement signals from one run feed into the next decision. Audience response shapes content direction before a human has reviewed the previous post. The system carries context forward rather than starting fresh each time.

Governance runs beneath every cycle, maintaining persona consistency, platform boundaries, and audience trust without requiring manual review at each step.

The shift is not about moving faster inside the same model. It is about operating inside a model where performance accumulates rather than resets where the value of each cycle builds on the one before it.

Intent goes in once. What the system learns compounds from there.

[Egger Butler @EButler69104]

building infra before validation risks scaling unproven drugs fast.

[LIFE AI @LifeNetwork_AI]

Today in Singapore, we took a question we have been working on at Life AI to a much bigger room.

As AI accelerates drug discovery, how do we build the operating infrastructure to move what we discover through clinical validation, evidence, and real-world execution?

Our Co-Founder & CEO Dr. Tuan Cao shared Life AI’s perspective on that question today at the NVIDIA Inception Grand Challenge Finale.

And much of the value lies in what follows: new perspectives, sharper questions, and meaningful connections across the industry.

Singapore extended the rails we’ve been laying, bringing our work into a broader conversation across AI, drug development, and healthcare.

And that is exactly where we want to be.

[Egger Butler @EButler69104]

@Mantle_Official @blockworksres $350M sounds strong until you check daily active wallets.

[XYO @OfficialXYO]

XYO共同創業者 Markus Levin が、AI経済の次のフェーズについてForbes JAPANに寄稿しました。

企業が見るべきは、AIがどれだけトークンを消費するかだけではありません。生産性、自律性、そして新たなビジネスモデルをどう生み出すか。ぜひご覧ください。

➡️https://t.co/s76AWXBnnP

[Egger Butler @EButler69104]

@TaraBull Zero Alpha in celebrity drama; if charged, market prices risk not denials.

[TaraBull @TaraBull]

I'm sure he'll get the best treatment in prison

[TaraBull @TaraBull]

Will Vivek Ramaswamy defy the odds? Only time will tell.

[Catturd ™ @catturd2]

This clown should’ve been held in contempt 1000 times by now.

[Egger Butler @EButler69104]

20 finalists out of thousands, yet most AI drug pitches stall at discovery. The real test is clinical validation.

[LIFE AI @LifeNetwork_AI]

The countdown to the NVIDIA Inception Grand Challenge Finale is on.

Tomorrow, our Co-Founder & CEO Dr. Tuan Cao will take the stage as one of the Top 20 finalists, sharing Life AI’s approach to building the operating infrastructure for AI-enabled drug development from accelerating discovery to clinical validation and real-world execution.

📅 September 22, 2026 | Singapore

If you’re joining us in Singapore, we’d love to connect.

[Egger Butler @EButler69104]

@BrownMikae55296 But ops layer without distribution is just theater. Who pays?

[MIKAEL BROWN @BrownMikae55296]

narrative says agents replace creators, but the loop still needs a human face to trust. keep building the ops layer, not the puppet.

[Egger Butler @EButler69104]

Slow recruitment? Or is AI quietly turning trials into closed data cartels? Who owns the pipeline when few giants control it?

[Spencer Anderson @Diana160548]

more candidates means more trials that can stall on slow patient recruitment, so ai just front-loads the bottleneck

[Egger Butler @EButler69104]

Charts look bullish, but liquidity above is thin. Spot CVD is flat while perps drive the move. That divergence usually resolves with a sharp wick. Watch $BTC at range highs.